COMMUNIQUÉS West-GlobeNewswire

Commit Biologics appoints serial biotech founder as new CEO to take complement-powered immune engagers into the clinic
11/03/2026
Dr. Thomas L. F. Montgomery Andresen joins from T-Cypher Bio Follows breakthrough non-human primate data demonstrating deep B-cell depletion without cytokine release Commit is poised to nominate its first two clinical [...]
Egg Medical présente les données CRT 2026 démontrant une voie responsable vers une protection légère sans plomb et sans tablier de plomb
11/03/2026
WASHINGTON, 11 mars 2026 (GLOBE NEWSWIRE) -- Egg Medical, leader dans le domaine des dispositifs de protection contre les rayonnements (ERPD), a annoncé aujourd’hui les résultats d’un essai de dernière minute présenté [...]
Propr® Introduces Propr Paste, Completing Its Clinically Inspired System for Gentle, Long-Term Oral Health
11/03/2026
New York, NY, March 11, 2026 (GLOBE NEWSWIRE) -- Propr ®, the fluoride free oral care brand founded by leading periodontist and educator Dr. Jack Gruber , today announced the launch of Propr Paste , the third product in [...]
Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Science, and Blood Cancer Treatment
11/03/2026
$250,000 top award goes to Connor Hill in America’s longest running and most distinguished science and math competition TARRYTOWN, N.Y. and WASHINGTON, March 10, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc [...]
Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Science, and Blood Cancer Treatment
11/03/2026
$250,000 top award goes to Connor Hill in America’s longest running and most distinguished science and math competition TARRYTOWN, N.Y. and WASHINGTON, March 10, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. [...]
Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering
11/03/2026
NEW YORK and WALTHAM, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH) (“Dianthus” or the “Company”), a clinical-stage biotechnology company dedicated to developing next-generation [...]
TrimX Drops Metabolism Claims Evaluated: Latest Report About TrimX Liquid Thermogenic Formula Ingredient Research & Effectiveness for Men & Women
11/03/2026
A 2026 consumer research report examining TrimX Drops metabolism marketing claims, liquid thermogenic formulation, ingredient-level research, and key verification considerations for adults researching weight management [...]
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
11/03/2026
VANCOUVER, British Columbia and BOSTON, March 10, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development [...]
Galapagos Receives Transparency Notifications from Bank of America
10/03/2026
Mechelen, Belgium ; March 10, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America. Pursuant to Belgian transparency legislation 1 [...]
The Leave-of-Absence Trap in Sham Peer Review Discussed in the Journal of American Physicians and Surgeons
10/03/2026
TUCSON, Ariz., March 10, 2026 (GLOBE NEWSWIRE) -- The latest addition to the hospital sham peer review playbook for removing undesired physicians is the leave-of-absence trap, writes Lawrence R. Huntoon , M.D, Ph.D., in [...]
Medicare Advantage Mental Health Coverage in New York: $0–$30 Online Therapy Sessions
10/03/2026
Manhattan Mental Health Counseling, the highest-rated affordable online therapy practice is now in-network with five major Medicare Advantage carriers. They now cover 78% of the state’s 1.8 million beneficiaries. NEW [...]
Longevity Based Releases New Report on Biohacking Recovery Technologies Used in CEO Jacob Gendron’s Longevity Routine
10/03/2026
Plant-based nutrition, strength training, and biohacking technology support his measured heart health. Los Angeles, CA, March 10, 2026 (GLOBE NEWSWIRE) -- Longevity Based , a Los Angeles-based wellness brand focused on [...]
R1 and Heidi Announce Strategic Partnership to Improve Revenue Capture for Physician Groups and Healthcare Organizations
10/03/2026
Partnership Integrates Heidi’s AI scribe technology into R1’s Phare Revenue Operating System, Bringing Reimbursement Accuracy into the Clinical Workflow CHICAGO and NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- R1, the [...]
Adverse Effects of COVID Vaccine on Skin Are Underrated, according to the Journal of American Physicians and Surgeons
10/03/2026
TUCSON, Ariz., March 10, 2026 (GLOBE NEWSWIRE) -- The skin-related adverse effects of COVID vaccines have been dismissed as “irrelevant” by experts and overlooked by the public, writes Jane M. Orient, M.D ., in the [...]
To Restore Trust, Doctors Need to Re-commit to the Oath of Hippocrates, according to the Journal of American Physicians and Surgeons
10/03/2026
TUCSON, Ariz., March 10, 2026 (GLOBE NEWSWIRE) -- The medical profession has traded its birthright for a mess of pottage called evidence-based medicine, writes Stephen Hughes, M.D., in the spring issue of the Journal of [...]
Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
10/03/2026
NEWTON, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers [...]
Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters’ option to purchase additional shares
10/03/2026
NORTHFIELD, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its secondary offering of 86,250,000 shares of Medline Inc.’s Class A common stock by [...]
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
10/03/2026
Initiated higher-dose CBeyond Expansion Study (Part C) to generate higher-exposure human safety and pharmacokinetic data with 400 mg and 600 mg IV cohorts; Received written FDA Type C meeting minutes; feedback is [...]
Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026
10/03/2026
Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the [...]

Pages